The influence of immunomodulatory treatment on the clinical course of multiple sclerosis. Kavaliunas A, Stawiarz L, Hedbom J, Glaser A, Hillert J Adv Exp Med Biol. 2015; 822:19-24. PMID: 25416973. Abstract CommentRecommendBookmarkWatch